233 related articles for article (PubMed ID: 10411888)
1. Crystallographic analysis of CD40 recognition and signaling by human TRAF2.
McWhirter SM; Pullen SS; Holton JM; Crute JJ; Kehry MR; Alber T
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8408-13. PubMed ID: 10411888
[TBL] [Abstract][Full Text] [Related]
2. The structural basis for the recognition of diverse receptor sequences by TRAF2.
Ye H; Park YC; Kreishman M; Kieff E; Wu H
Mol Cell; 1999 Sep; 4(3):321-30. PubMed ID: 10518213
[TBL] [Abstract][Full Text] [Related]
3. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.
Pullen SS; Labadia ME; Ingraham RH; McWhirter SM; Everdeen DS; Alber T; Crute JJ; Kehry MR
Biochemistry; 1999 Aug; 38(31):10168-77. PubMed ID: 10433725
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for self-association and receptor recognition of human TRAF2.
Park YC; Burkitt V; Villa AR; Tong L; Wu H
Nature; 1999 Apr; 398(6727):533-8. PubMed ID: 10206649
[TBL] [Abstract][Full Text] [Related]
5. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
[TBL] [Abstract][Full Text] [Related]
6. Structurally distinct recognition motifs in lymphotoxin-beta receptor and CD40 for tumor necrosis factor receptor-associated factor (TRAF)-mediated signaling.
Li C; Norris PS; Ni CZ; Havert ML; Chiong EM; Tran BR; Cabezas E; Reed JC; Satterthwait AC; Ware CF; Ely KR
J Biol Chem; 2003 Dec; 278(50):50523-9. PubMed ID: 14517219
[TBL] [Abstract][Full Text] [Related]
7. Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40.
Tsukamoto N; Kobayashi N; Azuma S; Yamamoto T; Inoue J
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1234-9. PubMed ID: 9990007
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for CD40 signaling mediated by TRAF3.
Ni CZ; Welsh K; Leo E; Chiou CK; Wu H; Reed JC; Ely KR
Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10395-9. PubMed ID: 10984535
[TBL] [Abstract][Full Text] [Related]
9. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the peptide binding preferences of three closely related TRAF paralogs: TRAF2, TRAF3, and TRAF5.
Foight GW; Keating AE
Protein Sci; 2016 Jul; 25(7):1273-89. PubMed ID: 26779844
[TBL] [Abstract][Full Text] [Related]
11. Distinct molecular mechanism for initiating TRAF6 signalling.
Ye H; Arron JR; Lamothe B; Cirilli M; Kobayashi T; Shevde NK; Segal D; Dzivenu OK; Vologodskaia M; Yim M; Du K; Singh S; Pike JW; Darnay BG; Choi Y; Wu H
Nature; 2002 Jul; 418(6896):443-7. PubMed ID: 12140561
[TBL] [Abstract][Full Text] [Related]
12. Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1.
Graham JP; Moore CR; Bishop GA
J Immunol; 2009 Sep; 183(5):2966-73. PubMed ID: 19667091
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-kappaB activation.
Fotin-Mleczek M; Henkler F; Hausser A; Glauner H; Samel D; Graness A; Scheurich P; Mauri D; Wajant H
J Biol Chem; 2004 Jan; 279(1):677-85. PubMed ID: 14557256
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of CD40 signaling intermediates.
Werneburg BG; Zoog SJ; Dang TT; Kehry MR; Crute JJ
J Biol Chem; 2001 Nov; 276(46):43334-42. PubMed ID: 11562359
[TBL] [Abstract][Full Text] [Related]
15. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.
Pullen SS; Dang TT; Crute JJ; Kehry MR
J Biol Chem; 1999 May; 274(20):14246-54. PubMed ID: 10318845
[TBL] [Abstract][Full Text] [Related]
16. Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins.
Takeuchi M; Rothe M; Goeddel DV
J Biol Chem; 1996 Aug; 271(33):19935-42. PubMed ID: 8702708
[TBL] [Abstract][Full Text] [Related]
17. CD40 signaling through a newly identified tumor necrosis factor receptor-associated factor 2 (TRAF2) binding site.
Lu LF; Cook WJ; Lin LL; Noelle RJ
J Biol Chem; 2003 Nov; 278(46):45414-8. PubMed ID: 12960157
[TBL] [Abstract][Full Text] [Related]
18. Role of tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) in distinct and overlapping CD40 and TNF receptor 2/CD120b-mediated B lymphocyte activation.
Munroe ME; Bishop GA
J Biol Chem; 2004 Dec; 279(51):53222-31. PubMed ID: 15485859
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling.
Arron JR; Pewzner-Jung Y; Walsh MC; Kobayashi T; Choi Y
J Exp Med; 2002 Oct; 196(7):923-34. PubMed ID: 12370254
[TBL] [Abstract][Full Text] [Related]
20. TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation.
He L; Grammer AC; Wu X; Lipsky PE
J Biol Chem; 2004 Dec; 279(53):55855-65. PubMed ID: 15383523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]